Conexeu Sciences Inc. Common Stock (CNXU) Stock Price

CNXUStock

$7.07

Market Cap$189.18M

P/E—

PEG Ratio—

Div yield—

Beta-1.98

CNXU Share Price Chart

Favorite Metrics

Price vs S&P 500 (4W)-10.43%

VGM Score14.81

CNXU Analyst Recommendations

Jul 2026

Aug 2026

4.14

Industry Peers — Orthopedic & Prosthetic Devices(33)

Symbol	Value Score	Growth Score	Momentum Score	Price
CNXUConexeu Sciences Inc. Common Stock	—	—	F	$7.07
ISRGIntuitive Surgical Inc.	D	B	C	$372.60
EWEdwards Lifesciences Corp	D	C	B	$90.21
STESTERIS plc	C	B	C	$233.78
ZBHZimmer Biomet Holdings, Inc.	B	C	B	$100.91
SNNSmith & Nephew plc	B	C	C	$28.97
ALGNAlign Technology Inc	B	D	C	$157.58
MSAMine Safety Incorporated	C	C	B	$190.34
ESTAEstablishment Labs Holdings Inc.	F	A	C	$70.64
ENOVEnovis Corporation	B	D	C	$24.90
CDRECadre Holdings, Inc.	C	C	C	$30.74
AVNSAvanos Medical, Inc.	B	D	C	$24.99
AVRAnteris Technologies Global Corp. Common Stock	F	D	B	$8.74
SMTISanara MedTech Inc. Common Stock	D	C	B	$34.57
ZJYLJIN MEDICAL INTERNATIONAL LTD. Class A Ordinary Shares	B	D	D	$2.34
INGNInogen Inc	B	D	C	$5.50
LAKELakeland Industries Inc	B	D	B	$11.86
SPAISafe Pro Group Inc. Common Stock	F	C	D	$4.63
MYOMyomo Inc.	C	B	A	$1.60
APTAlpha Pro Tech, Ltd.	A	D	C	$5.35
NTRBNutriband Inc. Common Stock	F	D	C	$4.46
COCHEnvoy Medical, Inc. Class A Common Stock	D	D	D	$0.69
MLSSMilestone Scientific, Inc. Common Stock	D	D	B	$0.50
LFWDLifeward Ltd. Ordinary Shares	B	D	B	$7.46
RGNTRegentis Biomaterials Ltd.	—	—	D	$2.00
HSCSHeartSciences Inc. Common Stock	F	F	B	$3.03
CUPRCuprina Holdings (Cayman) Limited Class A Ordinary Shares	—	D	C	$3.01
CLGNCollPlant Biotechnologies Ltd Ordinary Shares	C	F	D	$0.36
FEEDENvue Medical, Inc. Common Stock	A	F	F	$0.34
BBLGBone Biologics Corp Common Stock	—	—	D	$0.61
BBLGWBone Biologics Corp Warrants	—	—	F	$5.70
COCHWEnvoy Medical, Inc Warrant	—	—	C	$0.04
HSCSWHeartSciences Inc. Warrant	—	—	D	$0.04
NTRBWNutriband Inc. Warrant	—	—	D	$0.45

About Conexeu Sciences Inc. Common Stock

Conexeu Sciences Inc is an early-stage medical technology company. The company develops and supplies collagen-based technologies that helps doctors and patients regenerate tissue naturally, safely, and effectively. The company is focused on developing regenerative biomaterials that address relative needs in wound care, dentistry, and aesthetics. The company seek to provide physicians with device-based solutions that improve healing, restore soft tissue, and enhance patient outcomes across multiple clinical settings. The company focuses durable, and growing addressable markets in regenerative aesthetics, wound care, 3D-printed tissue structures, veterinary wound repair, and dental soft-tissue regeneration.